Identifying predictive factors for recurrence risk in pediatric craniopharyngioma after surgery using a clinical

Lihua Tian1, Liyong Zhong2

  • 1Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, No.119, South Fourth Ring Road West, Fengtai District, Beijing, China.

Discover Oncology
|November 25, 2025
PubMed

Insights

This study introduces a new nomogram to predict recurrence in pediatric craniopharyngioma (CP) patients. The tool identifies key risk factors like tumor size and visual disturbances, aiding in personalized patient management.

Area of Science:

  • Oncology
  • Pediatric Neurosurgery
  • Medical Informatics

Background:

  • Craniopharyngioma (CP) are WHO grade I tumors with high survival rates in pediatric patients but significant quality of life concerns.
  • Postoperative pediatric craniopharyngioma (CO-CP) patients face risks of tumor recurrence, necessitating accurate predictive tools.
  • Current risk stratification for CO-CP recurrence requires enhancement for improved patient outcomes.

Purpose of the Study:

  • To develop and validate a novel nomogram for predicting recurrence risk in postoperative pediatric craniopharyngioma patients.
  • To identify and quantify significant risk factors associated with CO-CP recurrence.
  • To provide a graphical tool for clinicians to assess individual patient recurrence probabilities.

Main Methods:

  • Retrospective analysis of 192 CO-CP patients treated between January 2012 and July 2019.
  • Patients were divided into training (n=115) and internal test (n=77) cohorts using random sampling.
  • LASSO regression identified risk factors; nomogram accuracy was assessed via ROC curves and DCA.

Main Results:

  • Tumor diameter (OR=9.22), visual disturbances (OR=4.13), preoperative neuroendocrine impairment (OR=2.45), and extent of resection (OR=0.27 for gross-total resection) were significant risk factors.
  • The nomogram achieved areas under the ROC curve of 0.777 (training) and 0.766 (internal test).
  • Clinical DCA demonstrated the nomogram's utility across a range of probability thresholds.

Conclusions:

  • The developed nomogram accurately predicts recurrence risk in postoperative pediatric craniopharyngioma patients.
  • Incorporating LASSO-selected endocrinological variables, the nomogram offers a practical tool for risk identification.
  • This tool builds upon existing classifications and aids in proactive patient management for improved quality of life.
Abstract